We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Top Buys

1
TSEM icon
Tower Semiconductor
TSEM
+$9.09M
2
LITE icon
Lumentum
LITE
+$8.24M
3
GLW icon
Corning
GLW
+$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

1
CNC icon
Centene
CNC
+$9.07M
2
MOH icon
Molina Healthcare
MOH
+$8.9M
3
ELV icon
Elevance Health
ELV
+$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCNCA icon
376
First Citizens BancShares
FCNCA
$24.6B
– –
-328
Closed -$704K
FICO icon
377
Fair Isaac
FICO
$29.2B
– –
-104
Closed -$176K
FULC icon
378
Fulcrum Therapeutics
FULC
$243M
– –
-6,615
Closed -$74.8K
GDOT icon
379
Green Dot
GDOT
$760M
– –
-32,744
Closed -$419K
GDS icon
380
GDS Holdings
GDS
$6.24B
– –
-13,271
Closed -$463K
GKOS icon
381
Glaukos
GKOS
$9.21B
– –
-3,770
Closed -$426K
GLD icon
382
SPDR Gold Trust
GLD
$130B
– –
-3,068
Closed -$1.22M
GLNG icon
383
Golar LNG
GLNG
$5.05B
– –
-39,362
Closed -$1.46M
GOOG icon
384
CALL
Alphabet (Google) Class C
GOOG
$4.22T
– –
-4
Closed -$3.28K
GOSS icon
385
CALL
Gossamer Bio
GOSS
$83.2M
– –
-2,401
Closed -$328K
GPCR icon
386
CALL
Structure Therapeutics
GPCR
$3.45B
– –
-512
Closed -$1.96M
GS icon
387
CALL
Goldman Sachs
GS
$314B
– –
-2
Closed -$36
HCSG icon
388
Healthcare Services Group
HCSG
$1.74B
– –
-66,839
Closed -$1.28M
HOOD icon
389
Robinhood
HOOD
$89.7B
– –
-6,619
Closed -$749K
HSAI
390
Hesai Group
HSAI
$2.36B
– –
-20,226
Closed -$453K
IBIO icon
391
iBio
IBIO
$68.6M
– –
-39,585
Closed -$76.4K
ICE icon
392
Intercontinental Exchange
ICE
$79B
– –
-4,087
Closed -$662K
IKT icon
393
Inhibikase Therapeutics
IKT
$331M
– –
-93,430
Closed -$192K
IMMX icon
394
Immix Biopharma
IMMX
$730M
– –
-31,755
Closed -$166K
IMNM icon
395
Immunome
IMNM
$2.53B
– –
-8,528
Closed -$183K
INBX icon
396
Inhibrx
INBX
$1.28B
– –
-346
Closed -$27.3K
INDV icon
397
CALL
Indivior Pharmaceuticals
INDV
$4.79B
– –
-587
Closed -$159K
INSM icon
398
CALL
Insmed
INSM
$23.5B
– –
-142
Closed -$20.3K
INSM icon
399
Insmed
INSM
$23.5B
– –
-3,692
Closed -$643K
IONS icon
400
CALL
Ionis Pharmaceuticals
IONS
$8.99B
– –
-285
Closed -$432K
14 15
16
17 18

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.